Myrofora Panagi

7PUBLICATIONS
28CO-AUTHORS
BiomaterialsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursTumour immunologyNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 18, 2026
Synthetic Inducible Bacteria Normalize the Microenvironment of Refractory Tumors, Potentiating Checkpoint Inhibitor Responses.

|May 02, 2026
Synthetic inducible bacteria normalize the microenvironment of refractory tumors, potentiating checkpoint inhibitor responses.

|Nov 28, 2025
Antiemesis Corticosteroids Potentiate Checkpoint Blockade Efficacy by Normalizing the Immune Microenvironment in Metastatic Murine Breast Cancer.

John D Martin, Koji Nagaoka, Myrofora Panagi

|Jun 28, 2024
Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in Sarcomas.

Antonia Charalambous, Fotios Mpekris, Myrofora Panagi

|Apr 05, 2024
Stabilizing Tumor-Resident Mast Cells Restores T-Cell Infiltration and Sensitizes Sarcomas to PD-L1 Inhibition.

Myrofora Panagi, Fotios Mpekris, Chrysovalantis Voutouri

|Jul 29, 2023
Gold Nanobipyramids for Near-Infrared Fluorescence-Enhanced Imaging and Treatment of Triple-Negative Breast Cancer.

Ioannis G Theodorou, Fotios Mpekris, Paris Papagiorgis

Pageof 2

Frequent Collaborators

7 joint publications

Triantafyllos Stylianopoulos

5 joint publications

Fotios Mpkeris

5 joint publications

Chrysovalantis Voutouri

4 joint publications

Christina Michael